TY  - JOUR
PY  - 2022//
TI  - State naloxone co-prescribing laws show mixed effects on overdose mortality rates
JO  - Drug science, policy and law
A1  - Duska, MaryKate
A1  - Rhoads, Jared M.
A1  - Saunders, Elizabeth C.
A1  - Onega, Tracy
SP  - e20503245221112575
EP  - e20503245221112575
VL  - 8
IS  - 
N2  - OBJECTIVETo examine the relative changes in opioid overdose mortality rates between states that have and have not adopted naloxone co-prescribing laws.<br><br>METHODSWe performed a synthetic control analysis. National Vital Statistics data for the years 2012?2018 were analysed, and five states with naloxone co-prescribing laws were examined: Arizona, Florida, Rhode Island, Vermont, and Virginia. Opioid overdose-related deaths were identified through cause-of-death ICD-10 codes.<br><br>RESULTSOur pooled analysis for all opioid-related deaths showed no significant changes in opioid-related mortality rates in treated states, post naloxone co-prescribing law adoption (?0.05; 95% CI: ?0.43, 0.33). Rates of other and unspecified narcotic-related mortality rates in Rhode Island were found to have decreased post-law adoption (?0.13; 95% CI: ?0.25, ?0.00).<br><br>CONCLUSIONSThese findings suggest that naloxone co-prescribing laws were not associated with changes to overall opioid overdose mortality rates, post-law adoption, during the study period. However, Rhode Island did see a decrease in other and unspecified narcotic-related mortality rates post-law adoption. This is perhaps due to the comprehensive nature of the state's law. As overall rates of naloxone co-prescribing remain low, interventions to enhance naloxone prescribing and distribution may be necessary for co-prescribing laws to impact opioid-related mortality rates.<p />  <p>Language: en</p>
LA  - en
SN  - 2050-3245
UR  - http://dx.doi.org/10.1177/20503245221112575
ID  - ref1
ER  -